Replies to post #33018 on Endonovo Therapeutics Inc (ENDV)

[Biotech_Tradez]

They have NO ABILITY to raise capital.

The company is debt-ridden thus the "spin-out" they are touting to rid themselves of the problem they created. Unfortunately, even if they spin out SofPulse, good luck raising money as an OTC penny stock.

That construction company deal is dead on arrival, expect it to be a footnote in one of the quarterly or annual reports.

This management team is not respected and thus will never be able to raise money from institutional investors.

[John_Vallay]

Concrete company was a another sad business plan and strategy.
Putting aside Alan Collier's ineptness in the medical device business, his inability to raise a single penny from a legitimate investment, only dealing with toxic financiers, THEN HE DECIDES to go into the concrete business.

That move shows his expectations for PEMF & Sofpulse because No CEO of a medical device company, that believed in the medical devices that he is selling, would even entertain a concrete company, but Alan Collier knows that Sofpulse does not sell, because it has never sold, and for the reason he wanted to buy a concrete company, which he failed at doing.

Concrete company. Just think about that. Alan Collier wanted to buy a concrete company using ENDV investors money.


Here is the press release Alan Collier issued. Almost every line has misleading or inaccurate wording, starting with the headline where it was a DEFINITIVE AGREEMENT. How many other lies can you identify?


Endonovo Therapeutics Signs Definitive Asset Purchase Agreement to Acquire A Highly Profitable Texas Concrete Construction Company

Los Angeles, CA., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB: ENDV) and Western Star Concrete LLC, a highly profitable Texas concrete construction company located in the greater Dallas region, today announced the signing of a definitive purchase agreement for Endonovo to acquire all of Western Star’s assets and business operations.

The Agreement is a unique opportunity to greatly enhance Western Star’s position as a regional leader in the specialty concrete construction sector with multiple expansion opportunities generally throughout the Southeast region of the US. Presently, Western Star business generates revenue with net annual operating profits of $6.3 million.

“The acquisition of the Western Star assets and the opportunities to expand into other geographic regions in Texas present significant opportunities to significantly increase company net cash flows. The current profitability and future demonstrable growth provides a great value for Endonovo and our shareholders”, CEO Alan Collier said in making the announcement. “This opportunity will be accretive for Endonovo’s valuation from year one. There will be significant potential for synergies estimated, under normal operating conditions and generate between $30 million and $60 million in revenues per year according to three-year lookback financial reporting,” he said.

Collier also pointed out: “The new Endonovo construction entity formed will aim to continue to generate a Compound Annual Growth Rate (CAGR) of an estimated 15% to 20% annually. Ongoing business will be structured and expanded through the already successful Western Star management team that, as an example produced 52% growth from 2020 to 2021. Western Star financial performance has sustained a 15% to 20% CAGR over a three-year financial lookback in the specialized concrete construction sector. Our vision for Western Star’s business expansion would have broad geographical reach with present marketing plans to expand into multiple Texas cities in the next few years.”